Azelaic acid

Azelaic acid is a lipid of Fatty Acyls (FA) class. Azelaic acid is associated with abnormalities such as Bacterial Infections and Infection. The involved functions are known as Anabolism, Signal Transduction, Plant Immunity, Signal and Signal Transduction Pathways. Azelaic acid often locates in Body tissue. The associated genes with Azelaic acid are AZI1 gene, FKBPL gene and MLL gene. The related lipids are sebacic acid.

Cross Reference

Introduction

To understand associated biological information of Azelaic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azelaic acid?

Azelaic acid is suspected in Infection, Bacterial Infections and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azelaic acid

MeSH term MeSH ID Detail
Acne Vulgaris D000152 35 associated lipids
Acne Keloid D000153 1 associated lipids
Alopecia Areata D000506 6 associated lipids
Arteriosclerosis D001161 86 associated lipids
Body Weight D001835 333 associated lipids
Drug Eruptions D003875 30 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Erythema D004890 22 associated lipids
Facial Dermatoses D005148 7 associated lipids
Heart Failure D006333 36 associated lipids
Inflammation D007249 119 associated lipids
Keratosis D007642 9 associated lipids
Leukemia D007938 74 associated lipids
Melanoma D008545 69 associated lipids
Melanosis D008548 4 associated lipids
Pain D010146 64 associated lipids
Pituitary Apoplexy D010899 1 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Psoriasis D011565 47 associated lipids
Rhinophyma D012224 1 associated lipids
Rosacea D012393 13 associated lipids
Dermatitis, Seborrheic D012628 10 associated lipids
Hyperpigmentation D017495 11 associated lipids
Hutchinson's Melanotic Freckle D018327 2 associated lipids
Dermatitis, Perioral D019557 4 associated lipids
Pituitary ACTH Hypersecretion D047748 1 associated lipids
Disease Resistance D060467 12 associated lipids
Per page 10 20 50 | Total 27

PubChem Associated disorders and diseases

What pathways are associated with Azelaic acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Azelaic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azelaic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azelaic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azelaic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azelaic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azelaic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Azelaic acid

Download all related citations
Per page 10 20 50 100 | Total 511
Authors Title Published Journal PubMed Link
Page MM et al. Ion chromatographic analysis of amines, alkanolamines, and associated anions in concrete. 2005 J Sep Sci pmid:15835735
Manosroi J et al. Enhancement of the release of azelaic acid through the synthetic membranes by inclusion complex formation with hydroxypropyl-beta-cyclodextrin. 2005 Int J Pharm pmid:15778061
Wolf JE Present and future rosacea therapy. 2005 Cutis pmid:15810803
van Zuuren EJ and Graber MA The rigor of trials evaluating Rosacea treatments. 2005 Cutis pmid:15810805
Callender VD Considerations for treating acne in ethnic skin. 2005 Cutis pmid:16164153
Punsalan T and Usatine RP Red facial rash with "granitos". 2005 J Fam Pract pmid:16144591
Roebuck HL Face up to rosacea. 2005 Nurse Pract pmid:16151303
Purdy S Acne vulgaris. 2005 Clin Evid pmid:16135322
Shirokova E et al. Identification of specific ligands for orphan olfactory receptors. G protein-dependent agonism and antagonism of odorants. 2005 J. Biol. Chem. pmid:15598656
Ziel K et al. Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin. 2005 Nov-Dec J Drugs Dermatol pmid:16302558
Fleischer A and Suephy C The face and mind evaluation study: an examination of the efficacy of rosacea treatment using physician ratings and patients' self-reported quality of life. 2005 Sep-Oct J Drugs Dermatol pmid:16167417
Weschler CJ Ozone's impact on public health: contributions from indoor exposures to ozone and products of ozone-initiated chemistry. 2006 Environ. Health Perspect. pmid:17035131
Del Rosso JQ et al. Azelaic acid gel 15%: clinical versatility in the treatment of rosacea. 2006 Cutis pmid:17354468
Goodman G Managing acne vulgaris effectively. 2006 Aust Fam Physician pmid:16969442
Purdy S Acne vulgaris. 2006 Clin Evid pmid:16973084
Liu RH et al. Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials. 2006 Arch Dermatol pmid:16924055
Fleischer AB The evolution of azelaic acid. 2006 Cutis pmid:16566281
Draelos ZD The rationale for advancing the formulation of azelaic acid vehicles. 2006 Cutis pmid:16566282
Elewski B and Thiboutot D A clinical overview of azelaic acid. 2006 Cutis pmid:16566283
Bikowski JB Case studies. 2006 Cutis pmid:16566284
Del Rosso JQ The use of topical azelaic acid for common skin disorders other than inflammatory rosacea. 2006 Cutis pmid:16566285
Nally JB and Berson DS Topical therapies for rosacea. 2006 J Drugs Dermatol pmid:16468288
Zhang JF et al. [Studies on chemical constituents in root tuber of Cynanchum auriculatum]. 2006 Zhongguo Zhong Yao Za Zhi pmid:17048663
Gupta AK et al. The treatment of melasma: a review of clinical trials. 2006 J. Am. Acad. Dermatol. pmid:17097400
Worret WI and Fluhr JW [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid]. 2006 J Dtsch Dermatol Ges pmid:16638058
Wolf JE et al. Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea. 2006 Cutis pmid:16706244
Draelos ZD et al. An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients. 2006 J Cosmet Dermatol pmid:17173568
Devereux M et al. Synthesis, Superoxide Dismutase Mimetic and Anticancer Activities of Metal Complexes of 2,2-Dimethylpentanedioic Acid(2dmepdaH(2)) and 3,3-Dimethylpentanedioic acid(3dmepdaH(2)): X-Ray Crystal Structures of [Cu(3dmepda)(bipy)](2). 6H(2)O and [Cu(2dmepda)(bipy)(EtOH)](2). 4EtOH (bipy = 2,2'Bipyridine). 2006 Bioinorg Chem Appl pmid:17497019
Akman A et al. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. 2007 Arch. Dermatol. Res. pmid:17710426
Elewski BE Rosacea trial comparing twice-daily azelaic acid gel 15% with once-daily metronidazole gel 1%. 2007 Cutis pmid:17330623
Stinco G et al. Relationship between sebostatic activity, tolerability and efficacy of three topical drugs to treat mild to moderate acne. 2007 J Eur Acad Dermatol Venereol pmid:17309452
Nojima S et al. Contact sex pheromone components of the cowpea weevil, Callosobruchus maculatus. 2007 J. Chem. Ecol. pmid:17394050
Hinz DC Efficiency improvement for sulfated ash determination by usage of a microwave muffle furnace. 2007 J Pharm Biomed Anal pmid:17280812
Manosroi A et al. Characteristics and anti-proliferative activity of azelaic acid and its derivatives entrapped in bilayer vesicles in cancer cell lines. 2007 J Drug Target pmid:17541842
Satoh M et al. Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. 2007 Circulation pmid:17562954
Colón LE et al. Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%. 2007 Cutis pmid:17500380
Gupta AK and Gover MD Azelaic acid (15% gel) in the treatment of acne rosacea. 2007 Int. J. Dermatol. pmid:17472690
Alevizos A et al. Acne treatments: consider these options--and issues. 2007 J Fam Pract pmid:17475157
Conde JF et al. Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. 2007 J Drugs Dermatol pmid:17679183
Prignano F et al. Therapeutical approaches in melasma. 2007 Dermatol Clin pmid:17662899
Maher HK Rosacea. 2007 AAOHN J pmid:18183803
Piskin S and Uzunali E A review of the use of adapalene for the treatment of acne vulgaris. 2007 Ther Clin Risk Manag pmid:18472984
Elewski BE et al. In reference to the October 2004 comprehensive overview of rosacea therapy. 2007 J. Am. Acad. Dermatol. pmid:17870440
van Zuuren EJ et al. Systematic review of rosacea treatments. 2007 J. Am. Acad. Dermatol. pmid:17190628
Erbil H et al. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma. 2007 J. Dermatol. pmid:17204097
Iraji F et al. Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris. 2007 Mar-Apr Indian J Dermatol Venereol Leprol pmid:17456913
Crea F et al. Sequestering ability of polycarboxylic ligands towards dioxouranium(VI). 2008 Talanta pmid:18585146
Gollnick H and Layton A Azelaic acid 15% gel in the treatment of rosacea. 2008 Expert Opin Pharmacother pmid:18803456
Lee GS Intravenous vitamin C in the treatment of post-laser hyperpigmentation for melasma: a short report. 2008 J Cosmet Laser Ther pmid:18830869
Thiboutot D Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. 2008 J Drugs Dermatol pmid:18246693
Stewart JJ Application of the PM6 method to modeling the solid state. 2008 J Mol Model pmid:18449579
Craythorne EE and Lawrence CM Observational study of topical imiquimod immunotherapy in the treatment of difficult lentigo maligna. 2008 Clin Med Oncol pmid:21892331
Kanitakis J Linea fusca in a male adolescent successfully treated with azelaic acid. 2008 J Eur Acad Dermatol Venereol pmid:18331308
Purdy S and Deberker D Acne vulgaris. 2008 BMJ Clin Evid pmid:19450306
Chen Z et al. Versatile synthesis strategy for carboxylic acid-functionalized upconverting nanophosphors as biological labels. 2008 J. Am. Chem. Soc. pmid:18278910
Herkenne C et al. In vivo methods for the assessment of topical drug bioavailability. 2008 Pharm. Res. pmid:17985216
Arizaga GG et al. Chemical modification of zinc hydroxide nitrate and Zn-Al-layered double hydroxide with dicarboxylic acids. 2008 J Colloid Interface Sci pmid:18243238
Thiboutot DM et al. Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea. 2008 J Drugs Dermatol pmid:18561584
Jones DA Rosacea, reactive oxygen species, and azelaic Acid. 2009 J Clin Aesthet Dermatol pmid:20967185
Melnik BC et al. Anti-acne agents attenuate FGFR2 signal transduction in acne. 2009 J. Invest. Dermatol. pmid:19225542
Rup S et al. The ultrasound-assisted oxidative scission of monoenic fatty acids by ruthenium tetroxide catalysis: influence of the mixture of solvents. 2009 Ultrason Sonochem pmid:18799341
Del Rosso JQ et al. Impact of order of application of moisturizers on percutaneous absorption kinetics: evaluation of sequential application of moisturizer lotions and azelaic acid gel 15% using a human skin model. 2009 Cutis pmid:19363903
Jung HW et al. Priming in systemic plant immunity. 2009 Science pmid:19342588
Panyosak A et al. Safety assessment of azelaic acid and its derivatives entrapped in nanovesicles. 2009 Hum Exp Toxicol pmid:19755450
Que SK and Bergstrom KG Hyperpigmentation: old problem, new therapies. 2009 J Drugs Dermatol pmid:19746682
Del Rosso JQ The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study. 2009 Cutis pmid:19746764
Korting HC and Schöllmann C Current topical and systemic approaches to treatment of rosacea. 2009 J Eur Acad Dermatol Venereol pmid:19508315
Thiboutot DM et al. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. 2009 J Drugs Dermatol pmid:19588640
Shah J Plants under attack: systemic signals in defence. 2009 Curr. Opin. Plant Biol. pmid:19608451
Parker JE The quest for long-distance signals in plant systemic immunity. 2009 Sci Signal pmid:19436056
Gooderham M Rosacea and its topical management. 2009 Skin Therapy Lett. pmid:19330270
Elsaie ML and Choudhary S Updates on the pathophysiology and management of acne rosacea. 2009 Postgrad Med pmid:19820288
Del Rosso JQ The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. 2009 J Clin Aesthet Dermatol pmid:20729951
Mostafa FF et al. Comparative study of some treatment modalities of rosacea. 2009 J Eur Acad Dermatol Venereol pmid:18705632
Smit N et al. The hunt for natural skin whitening agents. 2009 Int J Mol Sci pmid:20054473
Safoury OS et al. A study comparing chemical peeling using modified Jessner's solution and 15% trichloroacetic Acid versus 15% trichloroacetic acid in the treatment of melasma. 2009 Indian J Dermatol pmid:20049268
Fujitani K et al. Preparation of polycarboxylic acids by oxidative cleavage with oxygen / Co-Mn-Br system. 2009 J Oleo Sci pmid:19915320
Wu YH et al. Effects of Chinese herbal medicine combined with He-Ne laser on lipoperoxide and superoxide dismutase in chloasma patients. 2009 J Tradit Chin Med pmid:19894376
Ebanks JP et al. Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. 2009 Int J Mol Sci pmid:19865532
Goldgar C et al. Treatment options for acne rosacea. 2009 Am Fam Physician pmid:19725487
Culp B and Scheinfeld N Rosacea: a review. 2009 P T pmid:19562004
Zeng JP et al. 2,2'-(Heptane-1,7-di-yl)dibenz-imidazo-lium chloride nitrate monohydrate. 2009 Acta Crystallogr Sect E Struct Rep Online pmid:21582272
Niimura Y On the origin and evolution of vertebrate olfactory receptor genes: comparative genome analysis among 23 chordate species. 2009 Genome Biol Evol pmid:20333175
Patwardhan N Conference Report: ACSICON 2008. 2009 J Cutan Aesthet Surg pmid:20300376
Bowler PJ Impact on facial rejuvenation with dermatological preparations. 2009 Clin Interv Aging pmid:19503770
Sobottka A and Lehmann P [Rosacea 2009 : new advances in pathophysiology, clinical staging and therapeutic strategies]. 2009 Hautarzt pmid:19957073
Keri J and Shiman M An update on the management of acne vulgaris. 2009 Clin Cosmet Investig Dermatol pmid:21436973
Lanz C et al. Radiation metabolomics. 3. Biomarker discovery in the urine of gamma-irradiated rats using a simplified metabolomics protocol of gas chromatography-mass spectrometry combined with random forests machine learning algorithm. 2009 Radiat. Res. pmid:19630524
De Filippis D et al. Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats. 2009 J. Cell. Mol. Med. pmid:18429935
Bandyopadhyay D Topical treatment of melasma. 2009 Indian J Dermatol pmid:20101327
Yu JS and Kim AK Effect of combination of taurine and azelaic acid on antimelanogenesis in murine melanoma cells. 2010 J. Biomed. Sci. pmid:20804622
Merkviladze N et al. The efficacy of topical drugs in treatment of noninflammatory acne vulgaris. 2010 Georgian Med News pmid:20972276
Del Rosso JQ Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial. 2010 Cutis pmid:21229827
Li N et al. Effect of 1,4-cyclohexanediol on percutaneous absorption and penetration of azelaic acid. 2010 Int J Pharm pmid:20025951
Garelnabi M et al. Evaluation of a gas chromatography method for azelaic acid determination in selected biological samples. 2010 N Am J Med Sci pmid:22558586
Davis EC and Callender VD Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. 2010 J Clin Aesthet Dermatol pmid:20725554
Chae K et al. A multifaceted study of stigma/style cysteine-rich adhesin (SCA)-like Arabidopsis lipid transfer proteins (LTPs) suggests diversified roles for these LTPs in plant growth and reproduction. 2010 J. Exp. Bot. pmid:20667964
Verma P and Pathak K Therapeutic and cosmeceutical potential of ethosomes: An overview. 2010 J Adv Pharm Technol Res pmid:22247858
Chaouch S et al. Peroxisomal hydrogen peroxide is coupled to biotic defense responses by ISOCHORISMATE SYNTHASE1 in a daylength-related manner. 2010 Plant Physiol. pmid:20543092
Xia Y et al. The glabra1 mutation affects cuticle formation and plant responses to microbes. 2010 Plant Physiol. pmid:20699396